Suboxone and False Positive for Codeine on Drug Tests: What You Need to Know
Yes, Suboxone (buprenorphine/naloxone) can cause a false positive for codeine on immunoassay drug screens.
Why It Happens
- Buprenorphine is a semi-synthetic opioid (thebaine derivative) with structural similarities to morphine/codeine.
- Many immunoassays use antibodies targeting the morphine/codeine backbone; buprenorphine and its metabolite norbuprenorphine can cross-react.
- Suboxone does not contain codeine, morphine, or heroin.
What to Do If You're on Suboxone
- Disclose your prescription to the testing facility/clinician before the test.
- Request confirmatory testing (GC-MS or LC-MS/MS). These methods distinguish buprenorphine/norbuprenorphine from codeine/morphine/6-MAM with high specificity.
- Provide your prescribing physician's contact info for verification.
Key Points
- False positives are a known limitation of screening immunoassays.
- Confirmatory testing is the standard of care for any positive screen.
- Suboxone is a legitimate, evidence-based treatment for opioid use disorder—protected under ADA and confidentiality laws (42 CFR Part 2).
If you face adverse consequences from a false positive, request written confirmation of the confirmatory result and consult legal/advocacy resources if needed.
Prescription Medications - Related Articles
- AED Use: Removing Medication Patches for Safe Shock Delivery
- Identifying Canadian Medications: A Guide for Safety
- Metacam Dosage for Dogs: A Comprehensive Guide
- Pancreatin and Butterfat Digestion: Understanding Digestive Enzyme Support
- Generic vs. Brand Name Drugs: What's the Difference?
- Children's Tylenol (Acetaminophen): Weight-Based Dosing, Age Limits & Safety
- Percocet: Uses, Risks & What to Know
